Biohaven Q3 EPS $(1.44) Misses $(1.34) Estimate
Portfolio Pulse from Benzinga Newsdesk
Biohaven (NYSE:BHVN) reported a Q3 EPS loss of $(1.44), missing the consensus estimate of $(1.34) by 7.46%. This represents a 15.2% increase in losses compared to $(1.25) per share in the same quarter last year.
November 14, 2023 | 9:59 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biohaven's Q3 earnings reported a larger loss than expected, missing analyst estimates and showing an increased loss year-over-year.
Earnings misses typically result in negative investor sentiment and can lead to a short-term decline in stock price. The reported increase in year-over-year losses further compounds the negative outlook, suggesting a potential short-term negative impact on BHVN's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100